By Michael Erman Oct 7 (Reuters) – The pharmaceutical industry's top lobby group on Wednesday sued to invalidate the Trump administration's efforts to benchmark US drug prices to lower costs overseas
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
WORKERS AT BRITISH CONSULATE IN JERUSALEM REMOVE CONSULATE SIGNAGE AS ISRAELI SHUTDOWN DEADLINE EXPIRES, REUTERS…
By Greg Bensinger SAN FRANCISCO, Oct 7 (Reuters) - Amazon confirmed on Wednesday it had…
Oct 7 (Reuters) - Blue Origin is likely to pursue an initial public offering in…
Oct 8 (Reuters) - ABU DHABI NATIONAL INVESTMENT AND DEVELOPMENT : * ADID- QITAF HOLDING…
Oct 7 (Reuters) - The US National Hurricane Center said in its latest advisory on…
By Florence Tan SINGAPORE, Oct 8 (Reuters) - The number of vessels transiting the Strait…